Data show the platform is already changing
, an ultra-Trumpy conspiracy theorist in the House of Representatives, was in high spirits on October 27th. “of Twitter, at last took control of the company. His professed admiration for free speech is being celebrated on the right, whose denizens complain that controls over the spread of misinformation online are an affront to their liberties. This is having a big impact on who uses Twitter. Many more people follow left-wing accounts on the platform than right-wing ones.
The data present a clear trend. In the four days after Mr Musk took the keys to Twitter, Republican members of Congress collectively gained around 470,000 followers, or an average of 1,800 each. The surge in followers on the day after the deal’s completion was just over half the size of the increase in April. Ms Taylor Greene gained the most of any Republican in the four days after the deal: the number of followers of her official account grew by 7% .
These changes are likely to be a result of right-leaning users joining the platform and left-leaning users leaving. In April Twitter said that the sudden changes were driven by the creation and deactivation of accounts. Followers of Democratic accounts still outnumber Republican ones, so if anything the platform is becoming more balanced between the two parties. But the wave of new joiners may already be having an impact. An analysis by Bloomberg, a media company, found that mentions of an unspecified racial slur on the platform increased by 1,300% after Mr Musk’s acquisition. The word was tweeted 170 times every five minutes. Mr Musk has insisted that Twitter “cannot become a free-for-all hellscape”.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China outlines plan for ‘Government Affairs Big Data System’Three million datasets to be thoroughly integrated in the name of efficiency, e-government, and surveillance
Read more »
Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19 - TrialsAim To inform the oversight of future clinical trials during a pandemic, we summarise the experiences of the Data Monitoring Committee (DMC) for the Randomised Evaluation of COVID therapy trial (RECOVERY), a large-scale randomised adaptive platform clinical trial of treatments for hospitalised patients with COVID-19. Methods and findings During the first 24 months of the trial (March 2020 to February 2022), the DMC oversaw accumulating data for 14 treatments in adults (plus 10 in children) involving | 45,000 randomised patients. Five trial aspects key for the DMC in performing its role were: a large committee of members, including some with extensive DMC experience and others who had broad clinical expertise; clear strategic planning, communication, and responsiveness by the trial principal investigators; data collection and analysis systems able to cope with phases of very rapid recruitment and link to electronic health records; an ability to work constructively with regulators (and other DMCs) to address emerging concerns without the need to release unblinded mortality results; and the use of videoconferencing systems that enabled national and international members to meet at short notice and from home during the pandemic when physical meetings were impossible. Challenges included that the first four treatments introduced were effectively ‘competing’ for patients (increasing pressure to make rapid decisions on each one); balancing the global health imperative to report on findings with the need to maintain confidentiality until the results were sufficiently certain to appropriately inform treatment decisions; and reliably assessing safety, especially for newer agents introduced after the initial wave and in the small numbers of pregnant women and children included. We present a series of case vignettes to illustrate some of the issues and the DMC decision-making related to hydroxychloroquine, dexamethasone, casirivimab + imdevimab, and tocilizumab. Conclusions REC
Read more »
Apple patches actively exploited iPhone, iPad kernel vulnsPlus: Misconfigured server leaks Reuters data; VMware patches critical flaw in retired software; MalwareBytes apologies for a hoodie
Read more »
Sunak on collision course with City over ‘intervention power’\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Read more »
‘Mischief and delay’: How Musk and Twitter finally sealed the deal\n\t\t\tExclusive scoops\n\t\t\tSmart data to help spot risk and opportunity\n\t\t\tAnalysis of broader trends in M&A\n\t\t\tLex, our agenda-setting business commentary (Premium only)\n\t\t\tDue Diligence, an exclusive M&A newsletter (Premium only)\n\t\t
Read more »
Esma’s Verena Ross: safeguarding the EU’s financial markets\n\t\t\tExpert insights, analysis and smart data help you cut through the noise to spot trends,\n\t\t\trisks and opportunities.\n\t\t\n\t\tJoin over 300,000 Finance professionals who already subscribe to the FT.
Read more »